作者
Negin Amanat, Michelle McDonald, Craig Godfrey, Lynne Bilston, David Little
发表日期
2007/6/1
期刊
Journal of Bone and Mineral Research
卷号
22
期号
6
页码范围
867-876
出版商
John Wiley and Sons and The American Society for Bone and Mineral Research (ASBMR)
简介
We hypothesized that ZA treatment would bolster fracture repair. In a rat model for closed fracture healing, a single dose of ZA at 0, 1, or 2 wk after fracture significantly increased BMC and strength of the healed fracture. Delaying the dose (1 or 2 wk after fracture) displayed superior results compared with dosing at the time of fracture.
Introduction: Bisphosphonates are known to increase bone strength and thus the resistance to fracture by decreasing osteoclastic bone resorption. These properties may enable bisphosphonates to also increase the strength of fracture repair. Zoledronic acid (ZA) is a potent bisphosphonate with a high affinity for bone mineral, allowing bolus intraveous dosing in a range of indications. In this study, we examined the application of bolus dose ZA in endochondral fracture repair.
Materials and Methods: Carbon‐14 labeled ZA was used in a closed rat …
引用总数
20062007200820092010201120122013201420152016201720182019202020212022202320241517132322122416151816131320141245
学术搜索中的文章
N Amanat, M McDonald, C Godfrey, L Bilston, D Little - Journal of Bone and Mineral Research, 2007